Global High-Priority Regulatory Events — February 16, 2026

17-02-2026

17-02-2026

17-02-2026

17-02-2026

17-02-2026

17-02-2026

17-02-2026

MaxLinear, Inc. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on the affected officer, position, appointment or resignation, reasons, or quantitative impacts are disclosed.

• ·Event date: February 17, 2026
• ·Filing accession number: 0001288469-26-000017
• ·File size: 210 KB

17-02-2026

Sana Biotechnology, Inc. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or timing are explicitly stated. No quantitative data, performance metrics, or further governance implications are mentioned in the provided filing information.

• ·Accession Number: 0001193125-26-053294
• ·Filing size: 346 KB
• ·Event date aligns with filing date (2026-02-17), suggesting prompt disclosure within SEC 4-business-day requirement

17-02-2026

17-02-2026

Rockwell Automation, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-054744), disclosing an officer change under Item 5.02 related to departures of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons for change, or quantitative terms are disclosed.

17-02-2026

17-02-2026

17-02-2026

MGP Ingredients Inc filed an 8-K on February 17, 2026 (AccNo: 0000835011-26-000006), disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Specific details including names, titles, reasons for changes, or any quantitative impacts are NOT_DISCLOSED. No positive or negative metrics, financial data, or further context provided.

17-02-2026

LOUISIANA-PACIFIC CORP filed a Form 8-K on 2026-02-17 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, timing, or any financial metrics are disclosed. This appears to be a routine leadership disclosure with no quantified positive or negative impacts provided.

17-02-2026

EKSO Bionics Holdings, Inc. filed a multi-item Form 8-K on February 17, 2026, disclosing events under Items 1.01 (Entry into a Material Definitive Agreement), 2.02 (Results of Operations and Financial Condition), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.01 (Changes in Control of Registrant), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), 5.03 (Amendments to Articles of Incorporation or Bylaws), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, or quantitative impacts are disclosed. The combination of control changes, equity sales, and governance modifications suggests potential strategic shifts, dilution risks, and operational updates without further details provided.

17-02-2026

Portland General Electric Co /OR/ filed a Form 8-K on 2026-02-17 reporting multiple material items: entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item filing likely combining earnings release with new agreement and financing details. Specific transaction values, financial metrics, period-over-period changes, guidance, or impacts are NOT_DISCLOSED.

17-02-2026

Greenpro Capital Corp. filed an 8-K on February 17, 2026, under Item 1.01 disclosing entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No specific details on the agreement terms, transaction value, financial impacts, or other metrics are disclosed.

17-02-2026

Cineverse Corp. disclosed entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), representing a key strategic transaction; however, it also created a direct financial obligation (Item 2.03) and involved unregistered sales of equity securities (Item 3.02), potentially introducing leverage and dilution risks. Regulation FD disclosure was provided (Item 7.01) with financial statements and exhibits (Item 9.01). No specific deal terms, parties, values, or financial metrics are disclosed.

17-02-2026

JFB Construction Holdings filed an 8-K on February 17, 2026 (AccNo: 0001493152-26-006871), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for change, or any financial metrics are disclosed. Sector information is not specified.

• ·Filing date: 2026-02-17
• ·Accession Number: 0001493152-26-006871
• ·File size: 208 KB
• ·Event type: Officer Change

17-02-2026

Matthews International Corp filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, strategic impacts, or financial metrics are disclosed.

17-02-2026

Hyatt Hotels Corp filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names of individuals involved, appointment or resignation status, reasons for the change, and any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events were mentioned in the provided filing information.

17-02-2026

nVent Electric plc filed an 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement, transaction size, parties, financial impacts, or quantitative metrics are provided.

17-02-2026

SPACSphere Acquisition Corp. filed an 8-K on 2026-02-17 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) related to a merger/acquisition event. No specific details on deal structure, parties involved, valuation, financial terms, or strategic rationale were explicitly stated. Sector not specified, limiting assessment of market implications.

• ·Accession Number: 0001829126-26-001360
• ·File Size: 467 KB

17-02-2026

BioRestorative Therapies, Inc. filed an 8-K on 2026-02-17 reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, or quantitative metrics disclosed in the provided information. No positive or negative performance metrics, period-over-period changes, or guidance revisions are mentioned.

17-02-2026

Proem Acquisition Corp. I filed an 8-K on 2026-02-17 disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger or acquisition. The filing also covers unregistered sales of equity securities (Item 3.02), departures/elections of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific deal parties, structure, valuation, financial metrics, or impacts are disclosed.

17-02-2026

TG-17, Inc. filed a Form 8-K on February 17, 2026, under Item 1.01 disclosing entry into a material definitive agreement and Item 9.01 providing financial statements and exhibits. No details on the agreement's nature, counterparties, terms, value, or financial impacts are disclosed. This is a multi-item mandatory filing with no quantitative metrics or period-over-period comparisons provided.

17-02-2026

Bioxytran, Inc. filed an 8-K on 2026-02-17 disclosing Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, events, financial impacts, or quantitative metrics were provided in the filing summary. No positive or negative metrics were mentioned.

17-02-2026

Applied Digital Corp. filed an 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No quantitative details, financial impacts, positive or negative metrics, or period-over-period comparisons are provided in the available information.

17-02-2026

TE Connectivity plc filed an 8-K on February 17, 2026, reporting under Item 1.01 the entry into a material definitive agreement, under Item 1.02 the termination of a material definitive agreement, and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No quantitative details, financial impacts, positive or negative metrics, or directional changes were disclosed.

17-02-2026

Trinseo PLC filed a Form 8-K on February 17, 2026 (AccNo: 0001104659-26-015648), reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 a Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, transaction value, financial impacts, or performance metrics disclosed in the provided information. No quantitative data, period-over-period comparisons, or scheduled events are mentioned.

17-02-2026

Kennedy-Wilson Holdings, Inc. filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on the nature of the agreement, events, or exhibits are provided in the filing summary. No quantitative financial metrics, period-over-period comparisons, or directional impacts are mentioned.

17-02-2026

WESCO INTERNATIONAL INC filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the key position affected, individuals involved, reasons for the change, or any financial metrics are disclosed. This appears to be a routine governance disclosure with no quantified impacts mentioned.

17-02-2026

Trinity Industries Inc filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 notes financial statements and exhibits. No specific details on positions affected, individuals involved, reasons, or impacts are disclosed.

17-02-2026

Science Applications International Corp filed an 8-K on 2026-02-17 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. No quantitative financial metrics, performance comparisons, or market impacts are mentioned.

17-02-2026

Vulcan Materials Company filed an 8-K on February 17, 2026 (AccNo: 0001140361-26-005605), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely related to earnings or operational updates, but no specific financial metrics, positive or negative changes, guidance, or transaction details are disclosed in the provided information. All quantitative data and performance comparisons remain NOT_DISCLOSED.

17-02-2026

AIR INDUSTRIES GROUP filed a Form 8-K on February 17, 2026, reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with both mandatory (Items 1.01, 3.02) and voluntary (Item 7.01) disclosures. No quantitative details such as transaction values, share counts, financial impacts, or strategic context are disclosed.

17-02-2026

Crown PropTech Acquisitions filed an 8-K on 2026-02-17 (AccNo: 0001213900-26-016858) disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger/acquisition. Additional disclosures include Regulation FD under Item 7.01, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific deal structure, parties, valuation, metrics, or performance details are disclosed.

17-02-2026

MAINZ BIOMED N.V. filed a multi-item Form 8-K on February 17, 2026, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), departure/election of directors or officers and compensatory arrangements (Item 5.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). Specific details including transaction values, share counts, financial impacts, dollar amounts, or quantitative metrics are NOT_DISCLOSED. The combination of potential strategic agreement alongside equity issuances and rights changes suggests mixed implications, but lacks quantification for assessment.

17-02-2026

Kyndryl Holdings, Inc. filed an 8-K on 2026-02-17 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected (e.g., CEO, CFO), names, reasons for changes, timing, or impacts are provided in the filing summary. No quantitative data, financial metrics, or scheduled events are mentioned.

17-02-2026

M3-Brigade Acquisition V Corp. filed an 8-K on 2026-02-17 under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific merger/acquisition details, transaction values, parties involved, financial metrics, or period-over-period comparisons were explicitly stated in the filing information provided. Sector was not specified.

17-02-2026

Columbia Financial, Inc. filed an 8-K on February 17, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, timing, or impacts are provided in the available information. This is a required SEC disclosure for material leadership events, but lacks quantitative or qualitative context.

17-02-2026

17-02-2026

XFLH Capital Corp filed a Form 8-K on February 17, 2026, reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This multi-item filing signals significant corporate actions including a material agreement and potential equity dilution, but no specific transaction values, financial impacts, or further details are disclosed. No positive or negative metrics are provided, resulting in informational disclosure without directional bias.

17-02-2026

Blue Bird Corp filed an 8-K on 2026-02-17 disclosing Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or metrics are provided in the filing summary. No positive, negative, or flat performance metrics are disclosed.

17-02-2026

Churchill Capital Corp X/Cayman filed an 8-K on February 17, 2026, disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), marking a change in shell company status (Item 5.06). The filing also covers unregistered sales of equity securities (Item 3.02), material modifications to security holder rights (Item 3.03), changes in control (Item 5.01), director and officer changes including compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), and amendments to the code of ethics (Item 5.05). No specific financial metrics, deal values, or performance comparisons are disclosed.

17-02-2026

Cognex Corp filed an 8-K on February 17, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 7.01 covers Regulation FD Disclosure, and Item 9.01 lists financial statements and exhibits. Specific details including key position affected, appointment or resignation status, reasons for change, timing, names, and any quantitative data are NOT_DISCLOSED.

17-02-2026

TLGY ACQUISITION CORP filed an 8-K on 2026-02-17 under Item 8.01 Other Events related to a Merger/Acquisition event. No specific deal structure, parties involved, valuation, terms, financial metrics, or other quantitative details are disclosed in the provided filing metadata. Sector is not specified.

17-02-2026

Playtika Holding Corp. filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 references financial statements and exhibits. No specific transaction details, values, or impacts are disclosed.

17-02-2026

Intellinetics, Inc. filed a Form 8-K on 2026-02-17 disclosing multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing for most items, but no specific details on the agreement, obligation size, officer changes, dollar values, strategic rationale, or quantitative impacts are provided. No positive, negative, or flat metrics are mentioned.

17-02-2026

Invech Holdings, Inc. filed a Form 8-K on February 17, 2026, disclosing multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.01 (Changes in Control of Registrant), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), and 9.01 (Financial Statements and Exhibits). No specific details on transaction values, parties involved, financial impacts, or changes are provided in the filing summary. This multi-item filing indicates a potentially transformative corporate event such as a merger or acquisition leading to control changes, but lacks quantitative data for assessment.

17-02-2026

Graham Corp filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-053140), reporting under Item 5.02 on departure of directors or certain officers, election/appointment of directors/officers, and compensatory arrangements; Item 7.01 on Regulation FD disclosure; and Item 9.01 on financial statements and exhibits. Specific details including officer names, positions, reasons for change, timing, or any financial metrics are NOT_DISCLOSED. No quantitative data, performance comparisons, or scheduled events are mentioned.

17-02-2026

Gemini Space Station, Inc. filed an 8-K on 2026-02-17 disclosing results of operations and financial condition under Item 2.02 and an officer or director change, including potential compensatory arrangements, under Item 5.02. No specific details such as the key position affected, appointment or resignation status, reasons for the change, board impacts, financial metrics, or quantitative data are provided. The filing is informational with no disclosed positive or negative performance indicators.

17-02-2026

Cingulate Inc. filed an 8-K on 2026-02-17 disclosing events under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), alongside Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details including affected positions, names, appointment or resignation status, reasons, and any financial impacts are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, or scheduled events were mentioned.

17-02-2026

CNS Pharmaceuticals, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001683168-26-001066), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, timing, or any compensatory arrangements are disclosed. No quantitative metrics, financial data, or performance comparisons are provided.

17-02-2026

D. Boral Acquisition I Corp. filed an 8-K on 2026-02-17 announcing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, departure/election/appointment of directors/officers and compensatory arrangements under Item 5.02, amendments to articles of incorporation or bylaws or change in fiscal year under Item 5.03, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on deal parties, structure, valuation, synergies, or financial metrics are disclosed. No positive or negative performance metrics are provided in the filing summary.

17-02-2026

Nukkleus Inc. filed an 8-K on 2026-02-17 announcing the completion of an acquisition or disposition of assets under Item 2.01, with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on deal parties, structure, valuation, synergies, or financial impacts were disclosed. Sector not specified, limiting assessment of strategic implications.

17-02-2026

Bowman Consulting Group Ltd. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, timing, or any quantitative financial metrics are disclosed. This appears to be a routine governance disclosure without additional performance data.

17-02-2026

CPI Card Group Inc. filed an 8-K on 2026-02-17 (AccNo: 0001104659-26-015886, Size: 140 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, timing, or financial implications are explicitly stated in the provided filing summary. No quantitative metrics, performance comparisons, or other events are mentioned.

• ·Event date: 2026-02-17
• ·Source: us_sec
• ·Sector: NOT_DISCLOSED

17-02-2026

Masimo Corp filed a Form 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details provided on the agreement's nature, parties, terms, financial impacts, or any quantitative metrics such as transaction value, revenue effects, or guidance changes. No positive or negative metrics are disclosed, resulting in purely informational disclosure.

17-02-2026

VisionWave Holdings, Inc. filed a Form 8-K on 2026-02-17 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No details on the agreement terms, transaction value, financial impacts, strategic rationale, or any quantitative metrics are disclosed.

17-02-2026

Royal Caribbean Cruises Ltd filed a Form 8-K on February 17, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, reason for change, timing, or any quantitative metrics are provided.

17-02-2026

Kindly MD, Inc. filed a Form 8-K on February 17, 2026, reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, or financial metrics disclosed in the provided information. No positive or negative performance metrics are mentioned.

17-02-2026

Earth Science Tech, Inc. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on affected positions, individuals involved, reasons for the change, or any financial metrics are disclosed. No quantitative data, performance comparisons, or scheduled events are mentioned.

17-02-2026

Marriott Vacations Worldwide Corp filed an 8-K on February 17, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the affected officer's name, title, reason for departure or appointment, effective date, or internal/external status are disclosed. No quantitative financial metrics, performance comparisons, or governance impacts are provided in the available information.

17-02-2026

Lakeland Industries Inc filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-053267), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reason for change, or any quantitative impacts are disclosed. Sector is not specified, and no positive or negative metrics are mentioned.

17-02-2026

XTI Aerospace, Inc. filed a Form 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.03 material modifications to rights of security holders, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific transaction details, dollar values, financial metrics, positive or negative impacts, or period-over-period comparisons are disclosed in the provided filing summary. This is a multi-item filing likely involving financing or restructuring with potential balance sheet and shareholder implications.

17-02-2026

17-02-2026

Match Group, Inc. filed an 8-K on February 17, 2026 (AccNo: 0000891103-26-000022, Size: 162 KB), disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, timing, and any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned.

• ·Filing date: 2026-02-17
• ·Source: us_sec
• ·Sector: NOT_DISCLOSED

17-02-2026

VirTra, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001493152-26-006967), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on key positions affected, individuals, appointment/resignation status, reasons, timing, or governance implications were provided. No quantitative data, financial metrics, or scheduled events were mentioned.

17-02-2026

Xerox Holdings Corp filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-053333), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, or metrics provided in the filing summary. No quantitative data, period-over-period comparisons, or scheduled events are disclosed.

17-02-2026

MDWerks, Inc. filed an 8-K on February 17, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also includes Item 7.01 for Regulation FD disclosure and Item 9.01 for financial statements and exhibits. Specific details including names, positions, reasons for changes, timing, or any quantitative data are NOT_DISCLOSED.

17-02-2026

NATIONAL HEALTHCARE CORP filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment or resignation status, reasons for change, timing, or any quantitative impacts were provided. No positive or negative metrics, governance implications, or board outcomes were mentioned.

17-02-2026

C2 Blockchain, Inc. filed a Form 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and under Item 3.02 unregistered sales of equity securities. Item 9.01 provides financial statements and exhibits. No specific transaction values, parties, financial impacts, or other quantitative details are disclosed.

17-02-2026

SOUTHERN CO filed a Form 8-K on 2026-02-17 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, internal/external status, or timing are disclosed. No quantitative data, financial metrics, or other impacts are mentioned.

17-02-2026

Apple iSports Group, Inc. filed an 8-K on 2026-02-17 disclosing under Item 1.01 its entry into a material definitive agreement. No details regarding the nature of the agreement, counterparties, dollar value, financial terms, or strategic implications are provided in the filing summary. This is a single-item filing with no quantitative metrics, guidance changes, or scheduled events mentioned.

17-02-2026

Spartacus Acquisition Corp. II filed an 8-K on 2026-02-17 disclosing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, departures/elections/appointments of directors/officers under Item 5.02, amendments to articles of incorporation or bylaws under Item 5.03, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific deal parties, structure, valuation, financial metrics, synergies, or timelines were disclosed. Sector not specified.

17-02-2026

Goosehead Insurance, Inc. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). Specific details including the key position affected, appointment or resignation status, reasons, timing, and any financial metrics are NOT_DISCLOSED.

17-02-2026

Medalist Diversified REIT, Inc. filed an 8-K on 2026-02-17 (AccNo: 0001104659-26-016379) disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also covers creation of a direct financial obligation (Item 2.03), material modifications to rights of security holders (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific transaction parties, values, terms, financial metrics, synergies, or impacts are detailed.

• ·Accession Number: 0001104659-26-016379
• ·Filing size: 1 MB
• ·Sector: not specified

17-02-2026

17-02-2026

AIxCrypto Holdings, Inc. filed a Form 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 discloses financial statements and exhibits. No quantitative details, transaction values, financial impacts, or specific changes are provided in the filing summary.

17-02-2026

Boston Beer Co Inc filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-054573), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individual involved, reason for change, appointment or resignation status, timing, or any compensatory arrangements are disclosed. No quantitative data, financial metrics, or other changes are mentioned.

17-02-2026

P3 Health Partners Inc. filed a Form 8-K on February 17, 2026, disclosing under Item 1.01 its entry into a material definitive agreement. Item 9.01 reports financial statements and exhibits. No details on the agreement's terms, parties, value, financial impacts, or strategic rationale are provided.

17-02-2026

Yorkville Acquisition Corp. filed an 8-K on 2026-02-17 disclosing entry into a material definitive agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, and unregistered sales of equity securities under Item 3.02. Item 9.01 includes financial statements and exhibits. No quantitative metrics, deal terms, parties, or performance comparisons are disclosed, resulting in no identifiable positive or negative impacts.

17-02-2026

Solaris Energy Infrastructure, Inc. filed an 8-K on 2026-02-17 (AccNo: 0001193125-26-054550) disclosing officer changes under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, effective dates, or quantitative impacts are disclosed.

• ·Filing size: 237 KB
• ·Sector: not specified

17-02-2026

AST SpaceMobile, Inc. filed a multi-item 8-K on February 17, 2026, reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). While Items 1.01 and 2.03 suggest potential access to capital or financing, Item 3.02 indicates equity securities issuance that could dilute existing shareholders. No specific transaction values, terms, financial metrics, or impacts are disclosed.

17-02-2026

Q32 Bio Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001193125-26-054711), reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing for Item 1.01, with no specific details on the agreement, events, transaction size, financial impacts, or metrics provided in the available information.

17-02-2026

Safe & Green Development Corp filed a Form 8-K on February 17, 2026, disclosing entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). This multi-item filing signals a significant transaction involving financing or partnership activity, but no specific dollar values, share counts, or financial impacts are disclosed. No positive or negative metrics are provided, resulting in no directional bias.

17-02-2026

Annexon, Inc. filed a Form 8-K on February 17, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including names of individuals, positions affected, reasons for change, timing, or any quantitative compensation data are provided in the filing summary. This is a standard governance disclosure with no additional financial or operational metrics mentioned.

17-02-2026

Akamai Technologies Inc filed an 8-K on 2026-02-17 disclosing officer or director changes under Item 5.02, which covers departures, elections, appointments of certain officers or directors, and compensatory arrangements. Item 9.01 references financial statements and exhibits. No specific names, positions affected, reasons for change, or quantitative details provided.

• ·Sector: not specified
• ·Filing Accession Number: 0001086222-26-000004
• ·File Size: 231 KB

17-02-2026

Travelers Companies, Inc. filed an 8-K on February 17, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, or any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are mentioned.

17-02-2026

Quad/Graphics, Inc. filed an 8-K on 2026-02-17 disclosing changes related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative data are disclosed in the provided filing summary.

17-02-2026

Howard Hughes Holdings Inc. filed a Form 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 1.02 termination of a prior material definitive agreement, representing a multi-item filing with mixed implications. Item 8.01 discloses other events, while Item 9.01 includes financial statements and exhibits. No specific details, transaction values, financial impacts, or quantitative metrics are disclosed.

17-02-2026

ImageneBio, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-054684), disclosing matters under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions affected, reasons for changes, effective dates, or financial details such as compensation amounts are disclosed in the provided information. No quantitative metrics, performance comparisons, or additional context provided.

17-02-2026

Skillz Inc. filed an 8-K on 2026-02-17 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as key positions affected, names of individuals, reasons for the change, timing, or any quantitative data are provided in the filing summary. This appears to be an informational disclosure with no financial metrics or performance comparisons mentioned.

17-02-2026

NATURAL HEALTH TRENDS CORP filed an 8-K on 2026-02-17 (AccNo: 0001437749-26-004352, Size: 247 KB) reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, events, transaction value, parties, financial impacts, or metrics are disclosed. This is a multi-item mandatory filing with no period-over-period comparisons or quantitative data provided.

17-02-2026

AMERICAN ELECTRIC POWER CO INC filed an 8-K on 2026-02-17 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative impacts are disclosed. This appears to be a routine governance disclosure with no additional financial or operational metrics provided.

17-02-2026

CORE MOLDING TECHNOLOGIES INC filed an 8-K on 2026-02-17 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No specific details on the agreement's nature, parties, value, financial impact, or strategic implications are provided.

17-02-2026

Luvu Brands, Inc. filed an 8-K on 2026-02-17 reporting the completion of an acquisition or disposition of assets under Item 2.01. Item 9.01 provides financial statements and exhibits. No specific transaction details, financial metrics, parties involved, or values are disclosed.

17-02-2026

Advanced Micro Devices Inc. filed an 8-K on February 17, 2026 (AccNo: 0000002488-26-000029), disclosing information under Item 5.02 regarding departure of directors or certain officers; election of directors; appointment of certain officers; or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or impacts are disclosed. This is a routine SEC-required disclosure for leadership changes with no additional quantitative or qualitative context provided.

17-02-2026

NorthWestern Energy Group, Inc. filed a Form 8-K on 2026-02-17 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, or financial impacts are disclosed.

17-02-2026

Reborn Coffee, Inc. filed a Form 8-K on 2026-02-17 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected (e.g., CEO, CFO), individuals involved, appointment or resignation status, reasons for change, timing, or any quantitative data such as compensation amounts are disclosed. Sector is not specified.

17-02-2026

BullFrog AI Holdings, Inc. filed an 8-K on 2026-02-17 disclosing under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Item 9.01 includes Financial Statements and Exhibits. No additional financial metrics, reasons for delisting, or quantitative impacts are disclosed.

17-02-2026

Eos Energy Enterprises, Inc. filed a Form 8-K on 2026-02-17 reporting entry into a material definitive agreement under Item 1.01. Item 9.01 discloses financial statements and exhibits related to the agreement. No specific details on the agreement's parties, terms, value, financial impacts, or strategic context are provided.

17-02-2026

Apimeds Pharmaceuticals US, Inc. filed an 8-K on 2026-02-17 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing includes financial statements and exhibits under Item 9.01. No specific transaction details, parties, values, or financial impacts are disclosed.

17-02-2026

Awaysis Capital, Inc. filed an 8-K on February 17, 2026, disclosing under Item 1.01 the entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 references financial statements and exhibits. No specific details on transaction terms, dollar values, strategic rationale, or financial impacts are disclosed.

17-02-2026

Atossa Therapeutics, Inc. filed an 8-K on 2026-02-17 under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, transaction values, or additional details such as reasons for delisting, dollar impacts, or guidance changes were disclosed. This represents a material negative event with no offsetting positive information provided.

17-02-2026

Mereo BioPharma Group plc filed a Form 8-K on 2026-02-17 under Item 3.01 announcing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing from the US market. No quantitative financial metrics, transaction values, or additional details such as revenue impacts, balance sheet effects, or guidance changes were disclosed.

17-02-2026

Lithium Americas Corp. filed an 8-K on 2026-02-17 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, timing, or any quantitative metrics are provided. This appears to be a routine governance disclosure with no financial or performance data mentioned.

17-02-2026

Equity Bancshares Inc filed a Form 8-K on 2026-02-17 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), with Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure of a material event involving a new agreement and financial obligation. No quantitative details, transaction values, parties, impacts, or performance metrics (positive, negative, or flat) are disclosed.

• ·AccNo: 0001193125-26-054930
• ·File Size: 298 KB

17-02-2026

ARBOR REALTY TRUST INC filed an 8-K on 2026-02-17 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, names, reasons, or quantitative impacts are disclosed.

17-02-2026

WORLD ACCEPTANCE CORP filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment or resignation status, reasons, timing, or any financial metrics are disclosed.

17-02-2026

Falcon's Beyond Global, Inc. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the officer, position affected, reason for change, or any quantitative impacts are NOT_DISCLOSED.

17-02-2026

Inuvo, Inc. filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 references Financial Statements and Exhibits. No specific details on the agreement, transaction terms, financial impacts, or quantitative metrics are provided.

17-02-2026

CBL & Associates Properties Inc filed an 8-K on 2026-02-17 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were filed. No specific details on affected positions, individuals, reasons for change, or any quantitative metrics are disclosed.

17-02-2026

MarketAxess Holdings Inc filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-055003), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions, names of individuals, reasons for the change, effective dates, or any financial metrics are provided. No quantitative data, performance comparisons, or other material impacts are mentioned.

17-02-2026

Digital Brands Group, Inc. filed a multi-item Form 8-K on February 17, 2026 (AccNo: 0001493152-26-007183), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No quantitative data, transaction details, financial impacts, or specific agreements are disclosed in the provided filing summary. Critical details such as dollar values, share counts, and strategic context remain NOT_DISCLOSED.

17-02-2026

United Acquisition Corp. I filed an 8-K on February 17, 2026, disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01. No specific details on deal structure, parties, valuation, financial metrics, synergies, or impacts are explicitly stated in the filing summary provided. Critical transaction information such as deal size, consideration, and timeline is NOT_DISCLOSED, limiting comprehensive analysis.

17-02-2026

PSQ Holdings, Inc. filed a Form 8-K on 2026-02-17 under Accession No. 0001104659-26-016552 (297 KB), reporting a notice of delisting or failure to satisfy a continued listing rule or standard under Item 3.01. The multi-item filing also includes Item 2.02 on results of operations and financial condition and Item 9.01 for financial statements and exhibits. No specific financial metrics, reasons for delisting, transaction values, or quantitative impacts are disclosed.

17-02-2026

Andretti Acquisition Corp. II filed an 8-K on 2026-02-17 disclosing the termination of a material definitive agreement under Item 1.02. The filing also references financial statements and exhibits under Item 9.01. No specific details on the agreement parties, terms, financial impacts, or other metrics are provided.

17-02-2026

Bayview Acquisition Corp filed an 8-K on 2026-02-17 under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No quantitative financial metrics, deal structure details, parties involved, or merger/acquisition specifics are disclosed in the filing summary. Sector is not specified.

17-02-2026

Carpenter Technology Corp filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-054998, Size: 156 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, individual names, appointment or resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

17-02-2026

HOOKER FURNISHINGS Corp filed an 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction terms, financial metrics, or impacts are disclosed in the provided filing summary. This is a multi-item mandatory disclosure.

17-02-2026

Auddia Inc. filed a Form 8-K on 2026-02-17 reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 a Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details, terms, financial metrics, or quantitative impacts disclosed in the provided information. No positive or negative metrics are mentioned.

17-02-2026

Leidos Holdings, Inc. filed an 8-K on February 17, 2026, under Item 1.01 disclosing entry into a material definitive agreement and under Item 2.03 announcing the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No quantitative details, financial impacts, or strategic context are disclosed.

17-02-2026

Redwire Corp filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, individuals involved, reasons for the change, timing, or compensatory arrangements are disclosed. No quantitative financial metrics, performance comparisons, or other material data are provided.

17-02-2026

Healthy Choice Wellness Corp. filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with Item 9.01 providing financial statements and exhibits. No specific transaction details, dollar values, share counts, or financial impacts are disclosed. This is a multi-item filing with no period-over-period metrics or comparisons provided.

17-02-2026

Dorchester Minerals, L.P. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any named individuals are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or other numerical data are provided in the filing summary.

17-02-2026

EXICURE, INC. filed an 8-K on 2026-02-17 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed. This is an informational governance event with no additional performance or financial data provided.

17-02-2026

CIMG Inc. filed a Form 8-K on February 17, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, and under Item 3.02 unregistered sales of equity securities. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, share counts, or financial impacts are disclosed.

• ·Multi-item 8-K filing (Items 1.01, 2.03, 3.02, 9.01)

17-02-2026

DIRTT Environmental Solutions Ltd filed a Form 8-K on February 17, 2026 (AccNo: 0001193125-26-055157), reporting entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, and Regulation FD disclosure under Item 7.01. This is a multi-item filing with no specific transaction details, financial metrics, dollar values, or named individuals disclosed. No positive or negative performance metrics were provided, preventing assessment of directional impact.

17-02-2026

GeoVax Labs, Inc. filed an 8-K on February 17, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02. Regulation FD disclosure is provided under Item 7.01, accompanied by financial statements and exhibits under Item 9.01. No quantitative details such as transaction values, share counts, financial impacts, or period-over-period metrics are disclosed.

17-02-2026

Bally's Corp filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No quantitative details, transaction terms, dollar values, or financial impacts are disclosed.

17-02-2026

AirJoule Technologies Corp. filed an 8-K on February 17, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or terms are disclosed.